Atrial Fibrillation: Risk Stratification, Epidemiology, Treatment Advances and Prognostic Interventions

Dear Colleagues,

This Special Issue will explore current knowledge and innovations in managing atrial fibrillation (AF). AF is the most common sustained arrhythmia, with increasing prevalence linked to aging populations and lifestyle factors such as obesity. Obesity significantly elevates the risk of AF by promoting atrial remodeling, inflammation, and electrophysiological changes, making weight management a critical component of therapy. We are looking for submissions on risk stratification tools that can help to identify patients at higher risk of stroke and mortality, guiding anticoagulation and intervention strategies.

Recent advances in treatment include pulsed field ablation (PFA), a novel non-thermal technique offering precise and safe pulmonary vein isolation with reduced collateral damage. We also seek manuscripts exploring ablation outside the pulmonary veins, targeting additional atrial substrates responsible for more persistent and complex AF.

Overall, the progress in AF management emphasizes personalized therapies, incorporating cutting-edge procedures like PFA and targeted ablation outside pulmonary veins in more complex scenarios, with lifestyle modifications such as obesity reduction and management of multiple comorbidities playing a vital role in reducing disease burden and enhancing quality of life.

Prof. Dr. Rui Bebiano Da Providencia E Costa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.